Eisai
4523.T
$58.48
Share price
1.96%
Change (1 day)
31.42%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Revenue for Eisai (4523.T)
Revenue in 2023 (TTM): $5.48 B
According to Eisai's latest financial reports the company's current revenue (TTM) is $5.48 B. In 2022 the company made a revenue of $5.55 B a decrease over the years 2021 revenue that were of $6.36 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eisai from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $5.48 B | -1.18% |
| 2022 | $5.55 B | -12.69% |
| 2021 | $6.36 B | -4.62% |
| 2020 | $6.67 B | 9.99% |
| 2019 | $6.06 B | 6.52% |
| 2018 | $5.69 B | 12.19% |
| 2017 | $5.07 B | 3.14% |
| 2016 | $4.92 B | 4.87% |
| 2015 | $4.69 B | -9.82% |
| 2014 | $5.20 B | -12.56% |
| 2013 | $5.94 B | -15.59% |
| 2012 | $7.04 B | -15.34% |
| 2011 | $8.32 B | -11.35% |
| 2010 | $9.39 B | 12.42% |
| 2009 | $8.35 B |